NCT03564457

Brief Summary

Machine learn a predictive model from more than 20.000 non-small cell lung cancer patients from more than 5 health care providers from more than 5 countries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 20, 2018

Completed
11 days until next milestone

Study Start

First participant enrolled

July 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

March 8, 2019

Status Verified

March 1, 2019

Enrollment Period

3 months

First QC Date

June 11, 2018

Last Update Submit

March 7, 2019

Conditions

Non Small Cell Lung Cancer

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Overall survival

    2 years after (any) treatment for non small cell lung cancer

Study Arms (1)

One group of 20.000 patients

No interventions will take place as this is an observational study

Other: No interventions will take place (observational)

Interventions

No interventions will take place (observational)OTHER

No interventions will take place (observational)

One group of 20.000 patients

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients with non-small cell lung cancer who have been treated in one of the participating hospitals

You may qualify if:

  • Non small cell lung cancer
  • Treated in one of the participating hospitals

You may not qualify if:

  • No non small cell lung cancer
  • Not treated in one of the participating centers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MAASTRO clinic

Maastricht, 6229 ET, Netherlands

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • André Dekker, MD, PhD

    Maastro Clinic, The Netherlands

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2018

First Posted

June 20, 2018

Study Start

July 1, 2018

Primary Completion

October 1, 2018

Study Completion

October 1, 2018

Last Updated

March 8, 2019

Record last verified: 2019-03

Locations

NL(1)